HAEMONETICS CORP MASS - NOTE 3/0

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Debt / NOTE 3/0
Market price (% of par)
83.13%
Total 13F principal
$438,307,098
Principal change
-$6,326,857
Total reported market value
$364,276,052
Number of holders
48
Value change
-$4,237,742
Number of buys
13
Number of sells
18

Institutional Holders of HAEMONETICS CORP MASS - NOTE 3/0 as of Q4 2022

As of 31 Dec 2022, HAEMONETICS CORP MASS - NOTE 3/0 was held by 48 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $438,307,098 in principal (par value) of the bond. The largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, FRANKLIN RESOURCES INC, Kohlberg Kravis Roberts & Co. L.P., AVIVA PLC, OAKTREE CAPITAL MANAGEMENT LP, Linden Advisors LP, Aequim Alternative Investments LP, MACKAY SHIELDS LLC, OSTERWEIS CAPITAL MANAGEMENT INC, and DeepCurrents Investment Group LLC. This page lists 48 institutional bondholders reporting positions for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.